Sentinel Lymph Node in Breast Cancer: Review Article from a Pathologist’s Point of View

키워드

참고문헌 (58)

1. Trojani M, "Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance", Br J Cancer, 55, pp.303~306 (1987)
2. Hainsworth PJ, "Detection and significance of occult metastases in node-negative breast cancer", Br J Surg, 80, pp.459~463 (1993)
3. Clare SE, "Prognostic significance of occult lymph node metastases in node-negative breast cancer", Ann Surg Oncol, 4, pp.447~451 (1997)
4. Sedmak DD, "Prognostic significance of cytokeratin-positive breast cancer metastases", Mod Pathol, 2, pp.516~520 (1989)
5. Chen ZL, "Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology", Dis Markers, 9, pp.239~248 (1991)
6. de Mascarel I, "Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer followup", Br J Cancer, 66, pp.523~527 (1992)
7. Denoix PF, "Tumor, node and metastasis (TNM)", Bull Inst Nat Hyg (Paris), 1, pp.1~69 (1944)
8. Sobin LH, "TNM classification of malignant tumours" (2009), John Wiley and Sons Inc
9. Edge SB, "AJCC cancer staging manual" (2009), Springer
10. Giuliano AE, "Lymphatic mapping and sentinel lymphadenectomy for breast cancer", Ann Surg, 220, pp.391~398 (1994)
11. Fleming ID, "AJCC cancer staging manual" (1997), Lippincott-Raven
12. Singletary SE, "Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual", Surg Clin North Am, 83, pp.803~819 (2003)
13. Huvos AG, "Significance of axillary macrometastases and micrometastases in mammary cancer", Ann Surg, 173, pp.44~46 (1971)
14. Fisher ER, "Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases", Cancer, 42, pp.2032~2038 (1978)
15. Nasser IA, "Occult axillary lymph node metastases in “node-negative”breast carcinoma", Hum Pathol, 24, pp.950~957 (1993)
16. Greene FL, "AJCC cancer staging manual" (2002), Springer-Verlag
17. Bleiweiss IJ, "Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma", J Clin Oncol, 24, pp.2013~2018 (2006)
18. Fitzgibbons PL, "Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999", Arch Pathol Lab Med, 124, pp.966~978 (2000)
19. Hansen NM, "The time has come to change the algorithm for the surgical management of early breast cancer", Arch Surg, 137, pp.1131~1135 (2002)
20. Singletary SE, "Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual", CA Cancer J Clin, 56, pp.37~47 (2006)
21. Kim T, "Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis", Cancer, 106, pp.4~16 (2006)
22. McCready DR, "Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates", J Natl Cancer Inst, 96, pp.873~875 (2004)
23. Cserni G, "Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer", Br J Surg, 91, pp.1245~1252 (2004)
24. Viale G, "Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma", Cancer, 92, pp.1378~1384 (2001)
25. van Deurzen CH, "Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node", J Natl Cancer Inst, 100, pp.1574~1580 (2008)
26. Connolly JL, "Changes and problematic areas in interpretation of the AJCC Cancer Staging Manual, 6th Edition, for breast cancer", Arch Pathol Lab Med, 130, pp.287~291 (2006)
27. Cserni G, "Variations in sentinel node isolated tumour cells", micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions, 2008, pp.44, 2185~2191
28. Cserni G, "Improving the reproducibility of diagnosing micrometastases and isolated tumor cells", Cancer, 103, pp.358~367 (2005)
29. Cserni G, "Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting", Breast, 15, pp.347~354 (2006)
30. Turner RR, "Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training", J Clin Oncol, 26, pp.258~263 (2008)
31. de Mascarel I, "Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?", Cancer, 112, pp.1672~1678 (2008)
32. Cserni G, "Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM)definitions", Eur J Cancer, 47, pp.887~894 (2011)
33. Vestjens JH, "Relevant impact of central pathology review on nodal classification in individual breast cancer patients", Ann Oncol, 23, pp.2561~2566 (2012)
34. Apple SK, "Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma", Breast, 19, pp.360~364 (2010)
35. Lyman GH, "American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer", J Clin Oncol, 23, pp.7703~7720 (2005)
36. Chen SL, "The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis", Ann Surg Onc, 14, pp.3378~3384 (2007)
37. de Boer M, "Micrometastases or isolated tumor cells and the outcome of breast cancer", N Engl J Med, 361, pp.653~663 (2009)
38. Pugliese MS, "Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories", Ann Surg Oncol, 16, pp.113~120 (2009)
39. Hansen NM, "Impact of micrometastases in the sentinel node of patients with invasive breast cancer", J Clin Oncol, 27, pp.4679~4684 (2009)
40. Bilimoria KY, "Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer", J Clin Oncol, 27, pp.2946~2953 (2009)
41. Yi M, "Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database", Ann Surg Oncol, 17(Suppl 3), pp.343~351 (2010)
42. Cyr A, "Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection", Ann Surg Oncol, 19, pp.3185~3191 (2012)
43. Vergara-Lluri ME, "Recurrence rates in breast cancer patients who had sentinel lymph node biopsy alone versus completion axillary lymph node dissection: a 7-year clinical follow-up study", Breast J, 20, pp.666~668 (2014)
44. Fu Y, "Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?", Ann Surg Oncol, 21, pp.4109~4123 (2014)
45. Krag DN, "Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial", Lancet Oncol, 11, pp.927~933 (2010)
46. Giuliano AE, "Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial", JAMA, 305, pp.569~575 (2011)
47. Galimberti V, "Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial", Lancet Oncol, 14, pp.297~305 (2013)
48. Weaver DL, "Effect of occult metastases on survival in node-negative breast cancer", N Engl J Med, 364, pp.412~421 (2011)
49. Weaver DL, "Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy", Am J Surg Pathol, 33, pp.1583~1589 (2009)
50. Hieken TJ, "Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases: commentary on the IBCSG 23-01 Trial", Gland Surg, 2, pp.128~132 (2013)
51. Straver ME, "Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer", J Clin Oncol, 28, pp.731~737 (2010)
52. "The EORTC 10981-22023 AMAROS trial" (2010)[URL]
53. Mansel RE, "Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial", J Natl Cancer Inst, 98, pp.599~609 (2006)
54. Gill G, "Sentinel-lymphnode-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC):a randomized controlled surgical trial", Ann Surg Oncol, 16, pp.266~275 (2009)
55. Lucci A, "Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011", J Clin Oncol, 25, pp.3657~3663 (2007)
56. Cote RJ, "Role of immunohistochemical detection of lymph-node metastases in management of breast cancer", Lancet, 354, pp.896~900 (1999)
57. Guenther JM, "Axillary dissection is not required for all patients with breast cancer and positive sen tinel nodes", Arch Surg, 138, pp.52~56 (2003)
58. Tvedskov TF, "Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study", Breast Cancer Res Treat, 153, pp.599~606 (2015)

관련 논문AI추천